STC1 and cancer: STC1 has also been implicated in various cancer-related signaling pathways, including NF-kB, ERK1/2, JNK, and epithelial–mesenchymal transition (EMT), contributing to tumor initiation, invasion, metastasis, inflammation, and therapeutic resistance (55-57).